Segmented Ribose Binding Protein tags improve protein expression levels while maintaining high solubility for difficult-to-express targets.
Engineered Candida albicans expressing IL-17A and CXCL chemokines prevent candidiasis by converting pathogenicity into protective immune recruitment.
Targeting conserved IP-10 epitopes with specific antibodies suppresses harmful protein activity in autoimmune diseases.
Immobilized chemokines capture regulatory T lymphocytes via receptor binding in an apheresis column, reducing immune suppression and metastasis.
Mutated CXCL10 polypeptides enhance glycosaminoglycan binding affinity, resolving insufficient T-cell mobilization in inflammatory disorders.